These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 12109397

  • 1. Evaluation of the notification of hepatitis C risk to children who received unscreened blood or blood products.
    Langley JM, Squires SG, MacDonald DM, Anderson D, Peltekian K, Scott JW.
    Commun Dis Public Health; 2001 Dec; 4(4):288-92. PubMed ID: 12109397
    [Abstract] [Full Text] [Related]

  • 2. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
    Williams JL, Cagle HH, Christensen CJ, Fox-Leyva LK, McMahon BJ.
    Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
    Shuhart MC, Myerson D, Spurgeon CL, Bevan CA, Sayers MH, McDonald GB.
    Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of blood transfusion on the prevalence of hepatitis C virus antibodies in children with sickle cell anaemia in Enugu, South East Nigeria.
    Ejiofor OS, Ibe BC, Emodi IJ, Ikefuna AN, Ilechukwu GC, Emechebe G, Ilechukwu C.
    Niger J Clin Pract; 2009 Dec; 12(4):355-8. PubMed ID: 20329670
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risk of transfusion-transmitted hepatitis C virus in a tertiary hospital in Nigeria.
    Imarengiaye CO, Enosolease ME, Iribhogbe PE, Ehigiegba AE.
    Public Health; 2006 Mar; 120(3):274-8. PubMed ID: 16364383
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: theoretical risk for real people.
    King SM, Watson H, Heurter H, Ricketts M, Elsaadany S.
    CMAJ; 1998 Oct 06; 159(7):771-4. PubMed ID: 9805022
    [Abstract] [Full Text] [Related]

  • 14. HCV lookback in the United States: effectiveness of an extended lookback program.
    Menozzi D, Udulutch T, Llosa AE, Galel SA.
    Transfusion; 2000 Nov 06; 40(11):1393-8. PubMed ID: 11099671
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatitis C in children after transfusion: assessment by look-back studies.
    Roberts EA, King SM, Fearon M, McGee N.
    Acta Gastroenterol Belg; 1998 Nov 06; 61(2):195-7. PubMed ID: 9658607
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.